2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 14ÀÏ) : 2020-03-14±³À°ÀÏÀÚ : 2020-03-14
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿ÈúÈ£ÅÚ VISTA
±³À°ÁÖÁ¦ :
2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 14ÀÏ)ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
hematology@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í »çÀüµî·Ï 100,000¿ø ÇöÀåµî·Ï 200,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-14 VISTA 1 08:30~09:00 Working Party Reports Won Seog Kim(Samsung Medical Center)
±³À°½Ã°£ 03-14 VISTA 1 09:00~09:20 BiTing Leukemia: T Cell Recruiting Antibody Constructs for Treatment of AML Marion Subklewe(LMU-University Germany)
±³À°½Ã°£ 03-14 VISTA 1 09:20~09:40 The Emerging Role of MRD in AML Gert Ossenkoppele(VU University 'The Netherlands)
±³À°½Ã°£ 03-14 VISTA 1 09:40~10:00 Therapeutic Potential of Ascorbic Acid in TET2-Mutated AML Junshik Hong(Seoul National University)
±³À°½Ã°£ 03-14 VISTA 1 10:00~10:30 MRD in AML Byung Sik Cho(Catholic University of Korea)
±³À°½Ã°£ 03-14 VISTA 1 10:45~11:15 Latest Treatment Developments in Multiple Myeloma Nikhil Munshi(Dana-Farber Cancer Institute USA)
±³À°½Ã°£ 03-14 VISTA 1 11:15~11:45 Genetic Alterations in Relapsed/Refractory AML: Is There Something Special? Hyeoung-Joon Kim(Chonnam National University)